This page contains a Flash digital edition of a book.
Wednesday, June 6

1-2 p.m. | Session 3403 To End or Not To End? When Should Contact Precautions Be Discontinued? National Survey of Infection Preventionists Related to Contact Precautions for MRSA and VRE

There are currently no national guidelines with respect to when Contact Precautions can be terminated. This National Survey of Infection Preventionists related to practices associated with Contact Precautions for MRSA and VRE will showcase the current approaches to this dilemma. The results of the survey will be discussed in the context of strategies for addressing the growing burden of MRSA and VRE-colonized patients.

Paula J. Wright RN, BSN, CIC Director of Infection Control Massachusetts General Hospital

2:30-3:30 p.m. | Session 3600 Evolution of Long-Term Care in the U.S.: the Expanding Scope and Complexity of Infection Prevention

Nursing homes have become a crucial part of the U.S. healthcare system, with 1.5 million residents in 16,100 nursing homes at any given time, and a burgeoning short-stay population. This session will discuss the changes in nursing home industry and its implications on scope and practice of infection prevention.

Lona Mody, MD, MSc Associate Professor, University of Michigan University of Michigan and VA Ann Arbor Healthcare System

2:30-3:30 p.m. | Session 3601 Fecal Transplants

Did you ever, in your wildest dreams, imagine that stool would be a treatment therapy? This session will review the scientific rationale for fecal bacteriotherapy for patients with severe Clostridium difficile disease. Practical considerations such as the identification and screening of suitable recipients and donors, and the details of performing the procedure will be discussed to aid in the development of a program.

Stephen Parodi, MD

Chairman, The Permanente Medical Group Chiefs of Infectious Disease Kaiser Permanente

2:30-3:30 p.m. | Session 3603 State HAI Prevention

This presentation will discuss the growing role of state public health agencies and other state-based efforts in HAI prevention.

Arjun Srinivasan, MD

Associate Director for Healthcare Associated Prevention Programs The Centers for Disease Control and Prevention

2:30-3:30 p.m. | Session 3604

Infection Prevention in Ambulatory Oncology Treatment Centers

More and more cancer care is being provided in the outpatient setting. This session will review recently released resources and guidelines, developed by The Centers for Disease Control and Prevention, aimed at preventing infections in cancer patients in the ambulatory care setting.

Jennie Mayfield, MPH, CIC Clinical Epidemiologist Barnes-Jewish Hospital/Washington University School of Medicine

2:30-3:30 p.m. | Session 3605 Knocking at Your Door: New CMS Hospital Care Worksheet

Do you wonder whether you are prepared to respond to the new CMS Hospital Care survey? Participants will understand how the new hospital infection control survey tool was developed and about the change in survey strategy. There will be a review of the various sections and structure of the tool. Plus, the pre-test phase will be explained along with the next steps to implementation.

Daniel Schwartz, MD Chief Medical Officer

Survey and Certification Group

Centers for Medicare and Medicaid Services Office of Clinical Standards and Quality


Concurrent Sessions

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32